The role of inflammation in the pathogenesis of colorectal cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Colorectal Cancer Reports

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S11888-009-0011-ZPMID 19756239PMCID PMC2743014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin

  2009cited by this paper
• Colitis and cancer: a tale of inflammatory cells and their cytokines.

  2008cited by this paper
• NF-kappaB and cancer-identifying targets and mechanisms.

  2008cited by this paper
• Polymorphisms in Toll-like receptor genes and risk of cancer

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Role of Toll-like receptors in gastrointestinal malignancies

  2008cited by this paper
• Immunopathogenesis of inflammatory bowel disease.

  2008cited by this paper
• Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

  2008cited by this paper
• Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

  2008cited by this paper
• Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

  2008cited by this paper
• Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

  2007cited by this paper
• Inflammatory bowel disease: past, present, and future

  2007cited by this paper
• Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

  2007cited by this paper
• Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88

  2007cited by this paper
• A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

  2007cited by this paper
• Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

  2007cited by this paper
• Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin

  2007cited by this paper
• Tumour necrosis factor-alpha as a tumour promoter.

  2006cited by this paper
• Tumour necrosis factor-α as a tumour promoter

  2006cited by this paper
• TNF-alpha in promotion and progression of cancer.

  2006cited by this paper
• Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.

  2006cited by this paper
• TNF-α in promotion and progression of cancer

  2006cited by this paper
• Celecoxib for the prevention of sporadic colorectal adenomas.

  2006cited by this paper
• Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

  2005cited by this paper
• Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study

  2005cited by this paper
• Inflammation-associated cancer: NF-kappaB is the lynchpin.

  2005cited by this paper
• Inflammation-associated cancer: NF-κB is the lynchpin

  2005cited by this paper
• The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer

  2004cited by this paper
• Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.

  2004cited by this paper
• Role of cyclooxygenase-2 in colorectal cancer

  2004cited by this paper
• IKK Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

  2004cited by this paper
• Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

  2004cited by this paper
• The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.

  2004cited by this paper
• Tumour necrosis factor α: a potential target for the therapy of solid tumours

  2003cited by this paper
• Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

  2003cited by this paper
• Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.

  2002cited by this paper
• Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.

  2002cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Mouse by Rofecoxib , a Specific Cyclooxygenase-2 Inhibitor 716 ∆ Apc Chemoprevention of Intestinal Polyposis in the Updated Version

  2001cited by this paper
• Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease

  2000cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

  2000cited by this paper
• Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.

  2000cited by this paper
• Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Inflammation, reproduction, cancer and all that…. The regulation and role of the inducible prostaglandin synthase

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper

• Molecular Mechanisms Associated with the Inhibitory Role of Long Chain n-3 PUFA in Colorectal Cancer

  2024influential citation
• Potential therapeutic effects of crocin

  2024cites this paper
• Predictive modeling algorithms for liver metastasis in colorectal cancer: A systematic review of the current literature

  2023cites this paper
• Anti-inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease

  2022cites this paper
• Synergistic anticancer effects of curcumin and crocin on human colorectal cancer cells

  2022cites this paper
• Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease

  2022cites this paper
• Contribution of the Microbiota and their Secretory Products to Inflammation and Colorectal Cancer Pathogenesis: The Role of Toll-like Receptors.

  2021cites this paper
• Perioperative Blood Transfusions Are Associated With Worse Overall Survival But Not Disease-Free Survival After Curative Rectal Cancer Resection: A Propensity Score–Matched Analysis

  2021cites this paper
• The SELS rs34713741 Polymorphism Is Associated with Susceptibility to Colorectal Cancer and Gastric Cancer: A Meta-Analysis

  2020cites this paper
• Development of aldose reductase inhibitors for the treatment of inflammatory disorders and cancer: current drug design strategies and future directions.

  2020cites this paper
• Role of crocin in several cancer cell lines: An updated review

  2020cites this paper
• ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance

  2020cites this paper
• Role of inflammation in the development of colorectal cancer.

  2020cites this paper
• Assessment of tumor-suppressive inflammatory tendency of Echis coloratus venom against colon carcinogenesis, via up-regulation of anti-tumorigenic inflammatory cells and down-regulation of pro-tumorigenic inflammatory cells, in colon cancer cell lines

  2020cites this paper
• Use of the synbiotic VSL#3 and yacon-based concentrate attenuates intestinal damage and reduces the abundance of Candidatus Saccharimonas in a colitis-associated carcinogenesis model.

  2020cites this paper
• Evaluation of SEPP1 and Selenoprotein S Gene Polymorphisms (rs7579 and rs34713741) in Relation to Colorectal Cancer Susceptibility in Subset of Iranian Population: A Case–control Study

  2019cites this paper
• Colorectal cancer in inflammatory bowel disease: review of the evidence

  2019cites this paper
• Colorectal Cancer in Inflammatory Bowel Disease : What is the Real Risk and How Do We Manage It ?

  2019cites this paper
• Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer

  2019cites this paper
• Adverse Childhood Experiences among a Community of Resilient Centenarians and Seniors: Implications for a Chronic Disease Prevention Framework.

  2018cites this paper
• THE EFFECT OF LUNASIN FROM INDONESIAN SOYBEAN EXTRACT ON INDUCIBLE NITRIC OXIDE SYNTHASE AND β-CATENIN EXPRESSION IN DEXTRAN SODIUM SULFATE-INDUCED MICE COLON

  2018cites this paper
• Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study

  2018cites this paper
• The effect of lunasin from Indonesian soybean extract on histopatologic examination and cox-2 expression in dextran sodium sulfate-induced mice colon.

  2018cites this paper
• Establishment of a 12-gene expression signature to predict colon cancer prognosis

  2018cites this paper
• Annatto carotenoids attenuate oxidative stress and inflammatory response after high-calorie meal in healthy subjects.

  2017cites this paper
• Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis

  2017cites this paper
• Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

  2016cites this paper
• Carotenoids and Neurobiological Health.

  2016cites this paper
• MicroRNAs : Novel immunotherapeutic targets in colorectal carcinoma 2016 Colorectal Cancer : Global view

  2016cites this paper
• Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer

  2016influential citation
• MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

  2016cites this paper
• LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo

  2015cites this paper
• NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients

  2015cites this paper
• Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

  2015cites this paper
• Chronic Subordinate Colony Housing Paradigm: A Mouse Model to Characterize the Consequences of Insufficient Glucocorticoid Signaling

  2015cites this paper
• Effect of Exclusive Enteral Nutrition on the Microbiota of Children With Newly Diagnosed Crohn's Disease

  2015cites this paper
• The Chemokine CXCL 8 in Carcinogenesis and Drug Response

  2015cites this paper
• Developments in immunotherapy for gastrointestinal cancer.

  2015cites this paper
• Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.

  2015cites this paper
• Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

  2014cites this paper
• Chronic psychosocial stress-induced pathologies in male C57BL/6 mice - impact of the central oxytocinergic system

  2014cites this paper
• Bifidobacterium animalis ssp. lactis BI07 modulates the tumor necrosis factor alpha-dependent imbalances of the enterocyte-associated intestinal microbiota fraction.

  2014cites this paper
• Leaky Gut, Microbiota, and Cancer: An Incoming Hypothesis

  2014cites this paper
• Carotenoids, inflammation, and oxidative stress--implications of cellular signaling pathways and relation to chronic disease prevention.

  2014cites this paper
• Inflammation and colorectal cancer, when microbiota-host mutualism breaks.

  2014cites this paper
• Astaxanthin Structure , Metabolism , and Health Benefits

  2014cites this paper
• Structural Genomic Variation in TLR4 Gene and Cancer

  2013cites this paper
• The Chemokine CXCL8 in Carcinogenesis and Drug Response

  2013cites this paper
• Sulindac and Celecoxib Regulate Cell Cycle Progression by p53/p21 Up Regulation to Induce Apoptosis During Initial Stages of Experimental Colorectal Cancer

  2013cites this paper
• Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia

  2013cites this paper
• Organ Microbiota in Cancer Development: The Holy Grail of Biological Carcinogenesis

  2013cites this paper
• The role of mucus in the cross talk between gut bacteria and the host

  2013cites this paper
• Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice

  2012cites this paper
• Piste infectieuse et carcinogenèse colique : implication des Escherichia coli associés à la muqueuse

  2012cites this paper
• Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria

  2012cites this paper
• Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

  2012cites this paper
• The Role of Intestinal Barrier Function in Early Life in the Development of Colitis

  2012cites this paper
• Nrf 2 as a Chemopreventive Target in Colorectal Cancer

  2012cites this paper
• The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

  2011cites this paper
• Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen.

  2011cites this paper
• Pathobionts of the gastrointestinal microbiota and inflammatory disease.

  2011cites this paper
• Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer

  2011cites this paper
• Impact of Toll-like receptor 4 polymorphisms on risk of cancer.

  2011cites this paper
• Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands.

  2011cites this paper
• Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer

  2011cites this paper
• Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer

  2011cites this paper
• Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice.

  2011cites this paper
• Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer

  2011cites this paper
• γH2AX as a molecular marker of aging and disease

  2010cites this paper
• GammaH2AX as a molecular marker of aging and disease.

  2010cites this paper
• Role of CT colonography in screening programs

  2010cites this paper
• IDENTIFICATION OF COORDINATELY DYSREGULATED SUBNETWORKS IN COMPLEX PHENOTYPES by SALIM

  2010cites this paper
• Genetic variants in selenoprotein genes increase risk of colorectal cancer.

  2010cites this paper
• Body Size and Incident Colorectal Cancer: A Prospective Study of Older Women

  2010cites this paper
• In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.

  2010cites this paper
• E Durans Strain M4–5 Isolated From Human Colonic Flora Attenuates Intestinal Inflammation

  2010cites this paper
• Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome

  2010influential citation
• Subnetwork State Functions Define Dysregulated Subnetworks in Cancer

  2010cites this paper
• Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory

  2010cites this paper
• Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.

  2010cites this paper
• Chemoprevention of Colorectal Cancer by Targeting Janus Kinase 3 With a Rationally Designed Small Molecule Inhibitor

  2010cites this paper
• Regulation of tumor cell expression of the carbohydrate epitope sialyl Lewis X in the tumor microenvironment: implications for metastasis

  2010cites this paper